Di Tian board & 4 consecutive boards. Shanghai Highly (600619.SH) once again reminds: The revenue proportion of the cooling system used in lithography machines is less than one in ten thousand.
Haili Group (600619.SH) issued an announcement, stating that the company's A shares will be suspended from trading on September 20, 2024, and will resume on September 2...
Shanghai Highly (600619.SH) issued an announcement stating that the closing price of the company's A-shares on September 20th and September 23rd, 2024, had a cumulative deviation exceeding 20% for two consecutive trading days, which constitutes abnormal fluctuations in stock trading according to the relevant regulations of the Shanghai Stock Exchange.
The company has noticed related news reports and to avoid misleading investors, would like to remind once again: Shanghai Highly's main business includes the research, production, and sales of refrigeration rotary compressors, refrigeration motors, and castings, as well as the research, production, and sales of automotive thermal management systems and key component products mainly used in household air conditioning and automotive industries. The company's subsidiary Shanghai Haili Special Refrigeration Equipment Co., Ltd. ("Haili Special Refrigeration") is focused on the research and production of industrial equipment cooling systems, with its revenue mainly coming from the metallurgical industry's high-temperature air conditioning among other areas. Haili Special Refrigeration sells cooling systems for lithography machines, a business segment with a small scale, accounting for less than 0.003% of Shanghai Highly's annual revenue in the past three years.
Related Articles

Jangho Group's (601886.SH) subsidiary was awarded a contract for a approximately 1.12 billion yuan renovation project.

Guizhou Redstar Developing (600367.SH) subsidiary Dazhu Hongdie to cease production, with future operations to be taken over by Redsta.

Shanghai Haixin Group's subsidiary, Vitamin B6 Injection, passed the generic drug consistency evaluation.
Jangho Group's (601886.SH) subsidiary was awarded a contract for a approximately 1.12 billion yuan renovation project.

Guizhou Redstar Developing (600367.SH) subsidiary Dazhu Hongdie to cease production, with future operations to be taken over by Redsta.

Shanghai Haixin Group's subsidiary, Vitamin B6 Injection, passed the generic drug consistency evaluation.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


